Evidence map›Paper›PMID 39310261›Full record

ArticleInternational journal of medical sciences2024

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.

Xiaojie Zhao, Xin Yu, Wenge Li, Zhiyuan Chen, Tingting Niu, Xiaodong Weng, Lei Wang, Xiuheng Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaojie ZhaoDepartment of Urology, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.
Xin YuDepartment of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.
Wenge LiDepartment of Oncology, Shanghai Artemed Hospital, 200131 Shanghai, China.
Zhiyuan ChenDepartment of Urology, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.
Tingting NiuTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
Xiaodong WengDepartment of Urology, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.
Lei WangDepartment of Urology, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.
Xiuheng LiuDepartment of Urology, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorComputational BiologyCyclin-Dependent Kinase 6ImmunohistochemistryImmunotherapyTumor MicroenvironmentUrinary Bladder NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansMaleMutationPrognosisRetrospective StudiesBiomarkers, TumorCDK6 protein, humanCyclin-Dependent Kinase 6bladder cancercyclin-dependent kinase (CDK6)drug sensitivityimmunotherapyprognostic prediction

Identifiers

PMID39310261
PMCPMC11413897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.